Cargando…

Attractor – a new turning point in drug discovery

Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xucan, Li, Meng, Jia, Congmin, Zhang, Xianbao, Wang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709805/
https://www.ncbi.nlm.nih.gov/pubmed/31686779
http://dx.doi.org/10.2147/DDDT.S216397
_version_ 1783446244749737984
author Hou, Xucan
Li, Meng
Jia, Congmin
Zhang, Xianbao
Wang, Yun
author_facet Hou, Xucan
Li, Meng
Jia, Congmin
Zhang, Xianbao
Wang, Yun
author_sort Hou, Xucan
collection PubMed
description Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been proved to be a cue for the treatment of the complex diseases. The drug discovery methodology based on the attractor theory indicates new solutions for target identification, drug discovery and drug combination design. The methodology is based on the holism level of the organism and the features of system dynamics, so it has advantages for the classification of complex diseases and drug discovery. Currently, research results of this method have increased, which expand the insight scope for drug discovery. This article introduces the major drug discovery methods in the history of pharmacy development and their characteristics, so as to illustrate the reasons and inevitability of the appearance of attractor method, its position in the history of pharmacy development, and its advantages for drug discovery and design, thereby to prove that the attractor method can indeed become the next major drug development method. In addition, it provides a comprehensive description about the concept of attractor, the pipeline of attractor analysis, the common methods of each process and its research progress, so as to provide a macroscopic framework and optional methods and tools for the follow-up researchers.
format Online
Article
Text
id pubmed-6709805
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67098052019-11-04 Attractor – a new turning point in drug discovery Hou, Xucan Li, Meng Jia, Congmin Zhang, Xianbao Wang, Yun Drug Des Devel Ther Review Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been proved to be a cue for the treatment of the complex diseases. The drug discovery methodology based on the attractor theory indicates new solutions for target identification, drug discovery and drug combination design. The methodology is based on the holism level of the organism and the features of system dynamics, so it has advantages for the classification of complex diseases and drug discovery. Currently, research results of this method have increased, which expand the insight scope for drug discovery. This article introduces the major drug discovery methods in the history of pharmacy development and their characteristics, so as to illustrate the reasons and inevitability of the appearance of attractor method, its position in the history of pharmacy development, and its advantages for drug discovery and design, thereby to prove that the attractor method can indeed become the next major drug development method. In addition, it provides a comprehensive description about the concept of attractor, the pipeline of attractor analysis, the common methods of each process and its research progress, so as to provide a macroscopic framework and optional methods and tools for the follow-up researchers. Dove 2019-08-22 /pmc/articles/PMC6709805/ /pubmed/31686779 http://dx.doi.org/10.2147/DDDT.S216397 Text en © 2019 Hou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Hou, Xucan
Li, Meng
Jia, Congmin
Zhang, Xianbao
Wang, Yun
Attractor – a new turning point in drug discovery
title Attractor – a new turning point in drug discovery
title_full Attractor – a new turning point in drug discovery
title_fullStr Attractor – a new turning point in drug discovery
title_full_unstemmed Attractor – a new turning point in drug discovery
title_short Attractor – a new turning point in drug discovery
title_sort attractor – a new turning point in drug discovery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709805/
https://www.ncbi.nlm.nih.gov/pubmed/31686779
http://dx.doi.org/10.2147/DDDT.S216397
work_keys_str_mv AT houxucan attractoranewturningpointindrugdiscovery
AT limeng attractoranewturningpointindrugdiscovery
AT jiacongmin attractoranewturningpointindrugdiscovery
AT zhangxianbao attractoranewturningpointindrugdiscovery
AT wangyun attractoranewturningpointindrugdiscovery